February 7, 2022 Cancer/Oncology Case studies reported in Nature of decade-long leukaemia remissions after CAR T treatment. #GoScience
November 30, 2021 Bioengineering Kinematic-replicating xenobots constructed from frog embryonic cells. A fascinating window into how organizing cells in a specific configuration leads to a replicative behaviour not seen in cells or organisms.
November 24, 2021 Generic Drugs Will the COVID antiviral medications be the Thor’s Hammer against SARS-CoV-2 and help mitigate the ravages of the pandemic? These are impressive drugs but there are logistical, social, geographical, and financial caveats to solve in the process.
September 20, 2021 Genomics Two-year cancer-DNA-fragment screening blood test trial to start in England to assess sensitivity and specificity of early detection of numerous cancer types. If successful, it could lead to treatment of once difficult-to-detect early cancers.
August 23, 2021 Allergy/Immunology AstraZeneca is soon to publish results from its pre-exposure prophylaxis trial about anti-Covid antibodies given IM to people with comorbid states that reduce the immune response from vaccines. Reduced severe symptomatic risk (relative) by 77%.
May 27, 2021 Allergy/Immunology German study proposes a mechanism behind the rare blood clots associated with AstraZeneca vaccine.
May 3, 2021 Allergy/Immunology The development of mRNA vaccine technology has the potential to expand to treat and prevent other diseases akin to the technological spinoffs seen with the Apollo space program.
March 10, 2021 Allergy/Immunology New T-cell test to determine past exposure to SARS-CoV-2 is cool science but not a game changer. It may help answer why some become long-haulers after infection while others do not and it is a starting point for discovery and treatment research.
February 9, 2021 Allergy/Immunology Unpublished, uncontrolled small study claims that experimental exosome treatment shortens recovery time to five days for patients with severe Covid-19. Further human trials required to prove it truly works.
February 3, 2021 Bioengineering Excellent review of myths of enlisting more companies to make mRNA vaccine by @DerekLowe. Bespoke machines, processes & tech, multiple supply chains, a myriad of Sci & Eng expertise & steps needed before mass production. Many pharma companies can’t do it.